Associate Professor Meg Jardine


Program Head, Innovative Kidney Research and Head, Renal Trials, George Clinical Associate Professor, Faculty of Medicine, UNSW Sydney

A/Professor Meg Jardine is Program Head of Innovation & Kidney Research at The George Institute and Head of Renal Trials at George Clinical.

Her research interests centre on preventing the progression and complications of kidney disease and diabetes. She has a particular interest in using innovative trial designs to better generate evidence to improve outcomes. Dr Jardine leads the RESOLVE and BEAT-Calci trials and was the Global Scientific Lead of the CREDENCE study and CI of the ACTIVE and FINESSE trials. Her advocacy for kidney disease is pursued through memberships of the Board of the Kidney Health Initiative (KHI), the Executive Committee of the international KDIGO guidelines group and the International Society of Nephrology Advancing Clinical Trials (ISN-ACTS) core committee. 

Meg Jardine is a practising physician and nephrologist at Concord Repatriation General Hospital